Streetbeat News

Stock Prices

VUZI

Vuzix shares are trading higher following the announcement of receiving new additional orders from two aerospace and defense firms for the development and delivery of waveguide-based display solutions in 2024.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:09 pm

DIS

Disney CEO Bob Iger discussed the company's victory in its proxy battle against activist investors, emphasizing the distraction it caused and his relief over the outcome. Iger criticized Nelson Peltz for not bringing new ideas and potentially being a destructive presence on the board. The engagement during the proxy battle highlighted shared priorities among Disney's board, executives, and shareholders. Iger's focus will now return to core business priorities, including film quality, streaming profitability, ESPN's future, and the growth of Disney parks and resorts. Disney shares were up 0.73% at $119.85 following the news.

Portfolio Pulse from Erica Kollmann

April 04, 2024 | 4:07 pm

DASH

LOW

UBER

DoorDash Inc (NASDAQ:DASH) is expanding into the home improvement market through a partnership with Lowe's Companies Inc (NYSE:LOW), as highlighted by Benchmark analyst Mark Zgutowicz. Zgutowicz is bullish on DoorDash, initiating coverage with a Buy rating and a $165 price target, citing strong monetization potential in new verticals like grocery and convenience. The analysis points out DoorDash's significant market share advantage over Uber Technologies Inc's (NYSE:UBER) Uber Eats and its untapped potential in Retail Media advertising. Shares of DoorDash rose by 0.59% to $139.60.

Portfolio Pulse from Priya Nigam

April 04, 2024 | 4:05 pm

PBR

Petrobras shares are trading higher following an agreement between Brazilian ministers for the company to pay extraordinary dividends. This development is seen as a positive move for shareholders, potentially increasing the stock's attractiveness.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:02 pm

VVOS

Vivos Therapeutics' shares surged following the announcement of a notice of allowance for its U.S. patent application for a device aimed at treating sleep disordered breathing, sleep apnea, and snoring.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:01 pm

BV

Brightview Holdings Inc (NYSE:BV) shares fell after a recent surge, due to a downgrade by Goldman Sachs from Neutral to Sell, despite a price target increase from $8 to $10. The downgrade is based on the company's strategy to exit low-margin contracts, which is expected to negatively impact revenues, especially in its landscape maintenance business. Additionally, a warmer 2023-2024 winter is anticipated to reduce snow removal revenue, further challenging the company's financial outlook.

Portfolio Pulse from Priya Nigam

April 04, 2024 | 4:00 pm

BFH

Bread Finl Hldgs (NYSE:BFH) has been analyzed by 7 analysts, showing a shift towards a more positive outlook with an average 12-month price target of $38.29, up 18.43% from the previous $32.33. Analyst actions range from 'Outperform' to 'Underweight', reflecting diverse perspectives on the company's performance. Bread Financial, known for its credit card and loyalty program services, faces challenges in revenue growth and efficiency metrics but maintains a strong net margin.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 4:00 pm

F

TSLA

Tesla shares are trading higher, potentially due to Ford's delay in its all-electric SUV production. Additionally, Tesla is considering importing cars made at Giga-Berlin to India.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:00 pm

STAA

Staar Surgical (NASDAQ:STAA) has been evaluated by 4 analysts over the last three months, showing a mix of bullish and indifferent sentiments. The average 12-month price target is $44.5, reflecting a 4.71% increase from the previous $42.50. Analyst actions include maintaining, raising, and lowering ratings and price targets. Staar Surgical, a manufacturer of implantable lenses, has shown solid revenue growth of 19.09% as of December 31, 2023, with a net margin of 10.17% and exceptional ROE and ROA, indicating strong financial health.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 4:00 pm

ACHL

ALUR

CADL

CAG

EFTR

KWE

TCBP

Nasdaq rose 1% with ConAgra Brands reporting better-than-expected Q3 earnings, leading to a positive market sentiment. Real estate and healthcare sectors saw gains, while TC Biopharm, Allurion Technologies, and Candel Therapeutics experienced significant stock increases. Conversely, eFFECTOR Therapeutics, Achilles Therapeutics, and KWESST Micro Systems saw notable declines. Oil prices slightly dropped, while gold and silver prices increased.

Portfolio Pulse from Avi Kapoor

April 04, 2024 | 3:58 pm